Bicara Therapeutics Inc. Contracts & Agreements
15 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (4)
- Intellectual Property (1)
- Real Estate (2)
- Office Lease Agreement by and between Columbia Property Trust, Inc. and the Registrant, dated as of October 1, 2024 (Filed With SEC on November 12, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 6, 2024)
- Specimen Common Stock Certificate (Filed With SEC on September 6, 2024)
- Bicara Therapeutics Inc. 2024 Stock Option and Grant Plan and form of award agreements thereunder (Filed With SEC on September 6, 2024)
- Bicara Therapeutics Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on September 6, 2024)
- Form of Indemnification Agreement by and between the Registrant and each of its directors and executive officers (Filed With SEC on September 6, 2024)
- Non-Employee Director Compensation Policy (Filed With SEC on September 6, 2024)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated December 6, 2023 (Filed With SEC on August 22, 2024)
- 2019 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (Filed With SEC on August 22, 2024)
- Senior Executive Incentive Bonus Plan (Filed With SEC on August 22, 2024)
- Form of Executive Employment Agreement (Filed With SEC on August 22, 2024)
- Compensation Clawback Policy (Filed With SEC on August 22, 2024)
- Contract Transfer and License Agreement, by and between the Registrant and Biocon Limited, dated October 1, 2019 (Filed With SEC on August 22, 2024)
- Clinical Trial Collaboration and Supply Agreement, by and between the Registrant and MSD International GmbH and MSD International Business GmbH, dated May 19, 2022 (Filed With SEC on August 22, 2024)
- Office Lease Agreement, dated August 16, 2023 (Filed With SEC on August 22, 2024)
